PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $45,000 | +2.3% | 646 | -11.1% | 0.00% | 0.0% |
| Q4 2020 | $44,000 | +12.8% | 727 | +12.9% | 0.00% | -33.3% |
| Q3 2020 | $39,000 | +254.5% | 644 | +211.1% | 0.00% | +200.0% |
| Q2 2020 | $11,000 | +57.1% | 207 | +6.2% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -22.2% | 195 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $9,000 | +28.6% | 195 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,000 | +16.7% | 195 | +48.9% | 0.00% | 0.0% |
| Q2 2019 | $6,000 | +500.0% | 131 | +322.6% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 31 | -8.8% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 34 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 34 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 34 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 34 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |